BMS-986020 sodium

CAS: 1380650-53-2 货号: B655517 分子式: C29H25N2NaO5 分子量: 504.51 PubChem CID: 132274336
有货
级别和纯度: 10mM in DMSO
储存条件
干燥,-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
B655517-1ml
期货 Stock Image
¥1,276.90
请输入您要添加的产品数量

概述


BMS-986020 (AM152) sodium is a high-affinity lysophosphatidic acid receptor 1 ( LPA1 ) antagonist BMS-986020 sodium inhibits bile acid and phospholipid transporters with IC 50 s of 4.8 µM, 6.2 µM, and 7.5 µM for BSEP, MRP4, and MDR3, respectively BMS-986020 sodium has the potential for the treatment of idiopathic pulmonary fibrosis (IPF)

In Vitro

BMS-986020 sodium (0.1-10 nM; pre-incubated) concentration-dependent displacement of [ 18 F]BMT-083133 binding is observed in LPA1 + cells and lung sections. At 0.1 nM, the percent displacement in healthy mice, bleomycin mice, and IPF lungs is 18%, 24%, and 31%, respectively. At 10 nM, the percent displacement is 73%, 76%, and 64%, respectively. [ 18 F]BMT-083133, a radioligand targeting LPA1 is developed as a translational research tool for assessment of lung LPA1 engagement of BMS-986020 using in vitro autoradiography (ARG) . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

IC50& Target:IC50: 4.8 µM (BSEP),6.2 µM (MRP4),7.5 µM (MDR3)

规格

规格或纯度
10mM in DMSO
英文名称
BMS-986020 sodium
生化机理
BMS-986020 (AM152) 钠是一种高亲和力溶血磷脂酸受体 1 ( LPA1 ) 拮抗剂。BMS-986020 钠可抑制胆汁酸和磷脂转运体,对 BSEP、MRP4 和 MDR3 的 IC 50 s 分别为 4.8 µM、6.2 µM 和 7.5 µM [2
储存条件
干燥,-80℃储存
运输条件
特低温运输
作用类型
抑制剂
名称和识别符
分子类型
小分子
PubChem CID
分子量
504.51

高级数据

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器